BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31823142)

  • 1. Factors associated with and cutoff points for Patient Acceptable Symptom State (PASS) in rheumatoid arthritis.
    Katchamart W; Narongroeknawin P; Suppa-Udom B; Chanapai W; Srisomnuek A
    Clin Rheumatol; 2020 Mar; 39(3):779-786. PubMed ID: 31823142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis.
    Heiberg T; Kvien TK; Mowinckel P; Aletaha D; Smolen JS; Hagen KB
    Ann Rheum Dis; 2008 Jul; 67(7):967-71. PubMed ID: 17965118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Kvamme MK; Kristiansen IS; Lie E; Kvien TK
    J Rheumatol; 2010 Jan; 37(1):26-31. PubMed ID: 19955045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross-Sectional Study of 977 Patients.
    Puyraimond-Zemmour D; Etcheto A; Fautrel B; Balanescu A; de Wit M; Heiberg T; Otsa K; Kvien TK; Dougados M; Gossec L
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1504-1509. PubMed ID: 27998030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort.
    Kotak S; Mardekian J; Horowicz-Mehler N; Shah A; Burgess A; Kim J; Gemmen E; Boyd H; Koenig A
    Value Health; 2015 Sep; 18(6):817-23. PubMed ID: 26409609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Acceptable Symptom State in Self-Report Questionnaires and Composite Clinical Disease Index for Assessing Rheumatoid Arthritis Activity: Identification of Cut-Off Points for Routine Care.
    Salaffi F; Carotti M; Gutierrez M; Di Carlo M; De Angelis R
    Biomed Res Int; 2015; 2015():930756. PubMed ID: 26167506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Health-Related Quality of Life and Patient Acceptable Symptom State With Disease Activity and Functional Status in Patients With Ankylosing Spondylitis in Thailand.
    Chiowchanwisawakit P; Thaweeratthakul P; Wattanamongkolsil L; Srinonprasert V; Koolvisoot A; Muangchan C; Nilganuwong S; Arromdee E; Katchamart W
    J Clin Rheumatol; 2019 Jan; 25(1):16-23. PubMed ID: 29509563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease activity and functional status associated with health-related quality of life and patient-acceptable symptom state in patients with psoriatic arthritis in Thailand: A cross-sectional study.
    Chiowchanwisawakit P; Srinonprasert V; Thaweeratthakul P; Katchamart W
    Int J Rheum Dis; 2019 Apr; 22(4):700-707. PubMed ID: 30666824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis.
    Katchamart W; Narongroeknawin P; Sukprasert N; Chanapai W; Srisomnuek A
    Clin Rheumatol; 2021 Apr; 40(4):1291-1298. PubMed ID: 32955630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS Study.
    Gossec L; Steinberg G; Rouanet S; Combe B
    Clin Exp Rheumatol; 2015; 33(5):664-70. PubMed ID: 26344671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between patient acceptable symptom state and disease activity in patients with psoriatic arthritis.
    Fei JZ; Perruccio AV; Ye JY; Gladman DD; Chandran V
    Rheumatology (Oxford); 2020 Jan; 59(1):69-76. PubMed ID: 31199486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months.
    Bae SC; Cho SK; Won S; Lee HS; Lee SH; Kang YM; Lee SH; Lee YA; Choe JY; Chung WT; Suh CH; Shim SC; Lee J; Yoon BY; Kim DW; Lee SS; Yoo WH; Kim JS; Jung YO; Nah SS; Lee CK; Song GG; Choi SJ; Joung CI; Koh H; Kim YJ
    Int J Rheum Dis; 2018 May; 21(5):1001-1009. PubMed ID: 29878615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attainment of the Patient-acceptable Symptom State in 548 patients with rheumatoid arthritis: Influence of demographic factors.
    Duarte C; Santos E; Kvien TK; Dougados M; de Wit M; Gossec L; da Silva JAP
    Joint Bone Spine; 2021 Jan; 88(1):105071. PubMed ID: 32920168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis.
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf R; Hall C; Proudman SM; Wiese MD
    Int J Rheum Dis; 2017 May; 20(5):576-583. PubMed ID: 26692459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.
    Miwa Y; Takahashi R; Ikari Y; Maeoka A; Nishimi S; Oguro N; Hayashi T; Hatano M; Isojima S; Yanai R; Kasama T; Toyoshima Y; Inagaki K; Sanada K
    Intern Med; 2017; 56(8):903-906. PubMed ID: 28420837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parent and child acceptable symptom state in juvenile idiopathic arthritis.
    Filocamo G; Consolaro A; Schiappapietra B; Ruperto N; Pistorio A; Solari N; Pederzoli S; Verazza S; Martini A; Ravelli A
    J Rheumatol; 2012 Apr; 39(4):856-63. PubMed ID: 22298905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.
    Benham H; Rutherford M; Kirby S; Stebbings S; White D; Sim D; Harrison A
    Int J Rheum Dis; 2019 May; 22(5):874-879. PubMed ID: 30793870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.
    Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M
    Value Health; 2015 Dec; 18(8):1008-15. PubMed ID: 26686785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of satisfaction with rheumatoid arthritis treatment and associated alignment between physicians and patients across Latin America.
    Alves Pereira I; Maldonado Cocco J; Feijó Azevedo V; Guerra G; Bautista-Molano W; Casasola JC; Vega Morales D; Soriano ER; Gil DR; Zazzetti F; Aldunate L; Holdsworth EA; Massey O; Lobosco S; Lawson F
    Clin Rheumatol; 2020 Jun; 39(6):1813-1822. PubMed ID: 32030635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-acceptable symptom state as an outcome measure in the daily care of patients with ankylosing spondylitis.
    Rodríguez-Lozano C; Gantes MÁ; González B; Hernández-Beriain JA; Naranjo A; Hernández V; Quevedo-Abeledo JC; Falcón MJ; Machín S; Descalzo MA
    J Rheumatol; 2012 Jul; 39(7):1424-32. PubMed ID: 22660807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.